336 results on '"Groenink L"'
Search Results
52. Mouse strain differences in autonomic responses to stress
53. Mouse strain differences in autonomic responses to stress
54. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder
55. Effects of genetic background and null mutation of 5-HT(1A) receptors on basal and stress-induced body temperature: Modulation by serotonergic and GABA(A)-ergic drugs
56. Relationship of delay aversion and response inhibition to extinction learning, aggression, and sexual behaviour
57. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain
58. P.4.036 Corticotropin-releasing hormone and serotonin – the neuropsychopharmacology of fear learning deficit from rodents to humans
59. Stress-induced hyperthermia in the mouse: c-fos expression, corticosterone and temperature changes.
60. Urocortin expression in the Edinger-Westphal nucleus is down-regulated in transgenic mice over-expressing neuronal corticotropin-releasing factor.
61. Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)
62. P.4.d.003 Life-long CRF overproduction is associated with changes in functional sensitivity and gene expression of GABA-A and mGluR receptor subtypes
63. Stress-induced hyperthermia and anxiety: pharmacological validation.
64. Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs.
65. 5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety.
66. Operant learning and differential-reinforcement-of-low-rate 36-s responding in 5-HT1A and 5-HT1B receptor knockout mice.
67. (S)-UH301, a silent 5-HT(1A) receptor antagonist, enhances plasma cortiocosterone levels in the rat
68. HPA axis dysregulation in mice overexpressing corticotropin releasing hormone.
69. GABA(A)-benzodiazepine receptor complex sensitivity in 5-HT(1A) receptor knockout mice on a 129/Sv background.
70. Autonomic changes associated with enhanced anxiety in 5-HT(1A) receptor knockout mice.
71. SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model
72. P.2.09 Alterations in affective startle modulation: indicative of anhedonia?
73. Altered behavioural adaptation in mice with neural corticotrophin‐releasing factor overexpression
74. A35 THE ROLE OF THE 5-HT1A RECEPTOR IN THE DEVELOPMENT OF ANXIETY DISORDERS
75. B79 SEX-SPECIFIC EFFECTS ON STARTLE POTENTATION FOLLOWING EARLY LIFE STRESS
76. P.2.02 The 5-HT1A and GABAA-benzodiazepine receptors: Effects in behavior and pharmacology in female 5-HT1A knockout mice
77. S.2.1 Translation of animal models to humanpsychopathology
78. Urocortin expression in the Edinger-Westphal nucleus is down-regulated in transgenic mice over-expressing neuronal corticotropin-releasing factor
79. (S)-UH301, a silent 5-HT(1A) receptor antagonist, enhances plasma cortiocosterone levels in the rat
80. 5-HT1AReceptor Agonist Flesinoxan Enhances Fos Immunoreactivity in Rat Central Amygdala, Bed Nucleus of the Stria Terminalis and Hypothalamus
81. Repeated flesinoxan administration in rats: Dissociation of hormonal and behavioural effects
82. 5-HT1A receptors, anxiety and stress: Behavioural, neuroendocrine and physiological interfaces
83. Effects of cholecystokinin tetrapeptide (CCK4) on open field behaviour and potentiated startle in rats
84. SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.
85. 5-HT1A Receptor Agonist Flesinoxan Enhances Fos Immunoreactivity in Rat Central Amygdala, Bed Nucleus of the Stria Terminalis and Hypothalamus.
86. Footshock-induced sensitization of the acoustic startle response in two strains of mice
87. Stress-induced hyperthermia in the 5-HT1A receptor knockout mouse is normal
88. 5-HT1B receptor knockout, but not 5-HT1A receptor knockout mice, show reduced startle reactivity and footshock-induced sensitization, as measured with the acoustic startle response
89. 5-HT1A receptors, anxiety and stress: Behavioural, neuroendocrine and physiological interfaces
90. Pretreatment with 5-HT~1~A receptor agonist flesinoxan attenuates Fos protein in rat hypothalamus
91. The 5-HT~1~A Receptor Is Not Involved in Emotional Stress-Induced Rises in Stress Hormones
92. Neuroendocrine effects of diazepam and flesinoxan in the stress-induced hyperthermia test in mice
93. Long lasting effects of anti-depressants on olfactory bulbectomy induced hyperactivity in the open field
94. P.2.02 The 5-HT 1A and GABA A-benzodiazepine receptors: Effects in behavior and pharmacology in female 5-HT 1A knockout mice
95. P.3.22 Prefrontal cortex dysfunction in an animal model for neurodevelopmental psychopathological disorders
96. P.2.03 Effects of fluvoxamine on HPA-axis reactivity in transgenic mice overexpressing corticotropin-releasing factor
97. Stress-induced hyperthermia in mice: Hormonal correlates
98. The anxiolytic effects of flesinoxan, a 5-HT~1~A receptor agonist, are not related to its neuroendocrine effects
99. The corticosterone-enhancing effects of the 5-HT~1~A receptor antagonist, (S)-UH301, are not mediated by the 5-HT~1~A receptor
100. Experimental models of human anxiety - efficacy of antipanic agents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.